IMGENEX India Pvt. Ltd. has been awarded as an Emerging Company of the Year 2015 under Bio Industrial category in India. [View Details]
IMGENEX India in collaboration with Indian Agricultural Research Institute, New Delhi has been awarded a grant from BIRAC to develop detection kit for plant viruses.
IMGENEX India has been awarded a 3-year Phase II grant under the BIRAC scheme, Government of India to develop biosimilar Herceptin for the treatment of breast cancer.
ICMR releases detection kit for mutations in beta-thalassemia manufactured by IMGENEX India. [View Details]
Combating Neurological Diseases with Antibodies - PharmaBioWorld Dr. Lisa Stein, Director of Business, IMGENEX Corporation, San Diego, Dr Sujay Singh, CEO, IMGENEX Corporation, San Diego And IMGENEX India Pvt Ltd. [View Details]
Nanomedicine: Opening up big opportunities - Biospectrum Asia.
IMGENEX India has bagged the BioSpectrum Asia Pacific Emerging Company of the Year Award 2011. [View Details]
Mission: Tackling osteoporosis using nanobiotech - Biospectrum India IMGENEX India steps-up efforts to produce a nanobiotechnology osteoporosis drug at an affordable price, and with increased therapeutic value.
IMGENEX INDIA Pvt. Ltd.
E-5, Infocity, KIIT Post Office,
Bhubaneswar, Odisha - 751024, INDIA